During the past decade, Eunpyeong St. Mary's hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Eunpyeong St. Mary's hospital" #1 sponsor was "Pharmicell Co., Ltd." with 2 trials, followed by "Eli Lilly and Company" with 1 trials sponsored, "Genencell Co. Ltd." with 1 trials sponsored, "Kyung Hee University Hospital at Gangdong" with 1 trials sponsored and "Saint Vincent's Hospital, Korea" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eunpyeong St. Mary's hospital" #1 collaborator was "Genomictree, Inc." with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Eunpyeong St. Mary's hospital" are "Alcoholic Cirrhosis" (2 trials), "COVID-19" (2 trials), "Alopecia Areata" (1 trials), "Colon Polyp" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Eunpyeong St. Mary's hospital" in a lesser frequency.

Most popular intervention types in "Eunpyeong St. Mary's hospital" are "Drug" (3 trials), "Biological" (2 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Cellgram-LC" (2 trials), "Baricitinib" (1 trials), "ES16001 160 mg" (1 trials) and "ES16001 40 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eunpyeong St. Mary's hospital" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Eunpyeong St. Mary's hospital". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Eunpyeong St. Mary's hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Eunpyeong St. Mary's hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".